SCHEMBL7076598

SCHEMBL7076598

NC(=O)NC(=O)c1cc(N)c2ccccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.46
ACHE P22303 1/20 0.45
ADORA3 P0DMS8 3/20 0.44
GRM2 Q14416 6/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
NFKB1 P19838 1/20 0.41
RAB9A P51151 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
PIK3CA P42336 1/20 0.41
USP2 O75604 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6765144 0.98 NCF1 (0.45) NCF1ACHEADORA3GRM2L3MBTL1
SCHEMBL4501131 0.83 NCF1 (0.51) NCF1ACHEADORA3L3MBTL1POLB
SCHEMBL1314146 0.80 ALOX15 (0.58) NCF1ACHEADORA3GRM2MAPT
SCHEMBL1315731 0.77 KDM4E (0.52) NCF1ACHEMAPTMAPK1KMT2A
SCHEMBL12472848 0.74 NCF1 (0.51) NCF1ACHEGRM2MAPK1KMT2A
SCHEMBL14327479 0.73 RAB9A (0.46) GAAMAPTMAPK1KMT2ATDP1
SCHEMBL8539340 0.71 ALDH1A1 (0.52) NCF1ACHEGRM2L3MBTL1POLB
SCHEMBL8440112 0.69 ALOX15 (0.53) ACHEGRM2GAAKMT2ASMN1; SMN2
SCHEMBL31497721 0.68 SMN1; SMN2 (0.60) ADORA3L3MBTL1POLBGAAKMT2A
SCHEMBL1848398 0.68 NCF1 (0.60) NCF1ACHEADORA3L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244650-B1 ARYLAMINE DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT AVENTIS PHARMA SA (FR) 2003-06-25 EP claimed
EP-1244650-A1 ARYLAMINE DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT Aventis Pharma S.A. (FR) 2002-10-02 EP claimed
WO-2001040218-A1 ARYLAMINE DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT AVENTIS PHARMA S.A. (FR) 2001-06-07 WO claimed
EP-1244650-B1 ARYLAMINE DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT AVENTIS PHARMA SA (FR) 2003-06-25 EP disclosed
EP-1244650-A1 ARYLAMINE DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT Aventis Pharma S.A. (FR) 2002-10-02 EP disclosed
WO-2001040218-A1 ARYLAMINE DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT AVENTIS PHARMA S.A. (FR) 2001-06-07 WO disclosed